Medico-social problems of hospices in St.-Petersburg pediatric practice

2014 ◽  
Vol 5 (1) ◽  
pp. 82-89 ◽  
Author(s):  
Nikolay Ivanovich Vishnyakov ◽  
Yevgeniy Mikhaylovich Kutyrev ◽  
Zoya Anisimovna Sofiyeva ◽  
Sergey Ivanovich Gvozdarev
Keyword(s):  
Public Health ◽  
Health Service ◽  
Social Problems ◽  
Public Health Service ◽  
Adult Life ◽  
Pediatric Practice ◽  
Public Authorities ◽  
The Public ◽  
Economic Problems ◽  
Disease Prognosis

Children with an unfavourable disease prognosis require separate attention in the public health service of any state. A child with such disorder probably won’t enter into adult life. That fact creates a number of social and economic problems. In this article authors examine the work of the first in Russia children hospice in St. Petersburg and raise the problem of cooperation between hospices and other medical, non-medical organizations and public authorities.

Some economic problems and the public health service

Public Health ◽  
1931 ◽  
Vol 45 ◽  
pp. 377-379
Author(s):  
Leonard P. Lockhart
Keyword(s):  
Public Health ◽  
Health Service ◽  
Public Health Service ◽  
The Public ◽  
Economic Problems

Teaching in the Hospital and the Public Health Service

1917 ◽  
Vol 17 (12) ◽  
pp. 1176
Author(s):  
Ambrose L. Suhrie
Keyword(s):  
Public Health ◽  
Health Service ◽  
Public Health Service ◽  
The Public

Programs of the Cancer Control Program—U. S. Public Health Service

PEDIATRICS ◽  
1967 ◽  
Vol 40 (3) ◽  
pp. 527-528
Author(s):  
Charles J. A. Schulte
Keyword(s):  
Public Health ◽  
Cervical Cancer ◽  
Health Service ◽  
Public Health Service ◽  
Environmental Control ◽  
Cancer Control ◽  
Control Program ◽  
The United States ◽  
The Public ◽  
Cancer Control Program

ON JANUARY 1, 1967, the Cancer Control Program will become part of the National Center for Chronic Disease Control within the Public Health Service's new Bureau of Disease Prevention and Environmental Control. Our primary mission is to stimulate and encourage the application of currently available techniques of cancer prevention, cancer detection, and cancer control to the community at the grass roots level. If this will be the case after the reorganization remains to be seen. Figure 1 shows the new organization of the Public Health Service. By way of illustration, I think it would be well to briefly outline a few of our activities. An area of heavy emphasis has been the use of the Papanicolaou smears for cervical cancer control. These programs have been responsible for developing certified cytotechnology training schools, supporting and training large numbers of cytotechnicians. In addition, we are supporting some 90 hospital-based cervical cancer screening projects across the country. A program to encourage the general practitioner to screen his private patients in the office is jointly sponsored by the American Academy of General Practice and the Cancer Control Program. The very grave problem in the United States of smoking and carcinoma of the lung is the major responsibility of tile National Clearinghouse for Smoking and Health, a part of the Division of Chronic Diseases which developed out of the Cancer Control Program. We are engaged in a number of developmental projects, such as the flexible fiber optic proctosigmoidoscope. We hope to be able to produce a proctosigmoidoscope that will reach the splenic flexure.

Letters to the Editor

PEDIATRICS ◽  
1967 ◽  
Vol 40 (4) ◽  
pp. 691-693
Author(s):  
STARKEY D. DAVIS ◽  
RALPH J. WEDGWOOD
Keyword(s):  
Public Health ◽  
Placebo Group ◽  
Health Service ◽  
Excess Mortality ◽  
Public Health Service ◽  
Letters To The Editor ◽  
The Public ◽  
Mental Hospitals ◽  
The One ◽  
Isoniazid Prophylaxis

Dr. Yerushalmy points out the excess mortality in the isoniazid pupulation in two trials: contacts of new cases and patients in mental hospitals. He failed to mention that the Public Health Service has conducted five other isoniazid prophylaxis trials (Table I). In the six trials listed, excluding the one in institutions, the isoniazid groups had more deaths in three trials, the placebo group had more deaths in two trials, and in one trial the number of deaths in each group was equal.

Sign in / Sign up

Export Citation Format

Share Document